OptimizeRx Corp

OPRXNASDAQ · USD
7.62USD0.00 (+0.80%)
857

OptimizeRx Corp (OPRX) Covered Calls

As of September 21, 2026, OPRX has 4 covered call opportunities in the coming three months. Return ranges from 32.9 to 68.0% until expiration. Annualized return ranges from 80.6 to 200.4%. The nearest expiration is November 20, 2026. Maximum potential profit is $514.

Read more

Running OPRX covered calls helps you generate consistent income from OptimizeRx Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on OptimizeRx Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best OPRX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if OPRX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling OPRX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given OptimizeRx Corp covered call is worth writing.

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products.

In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

Income-focused investors, long-term OPRX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling OPRX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best OptimizeRx Corp covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryHealth Information Services
  • SectorHealthcare
  • IV percentile10.32% Subdued
  • Market cap (M$)144
  • 52 weeks high-65.75%
  • 52 weeks low67.84%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$12.40
    62.73% above the current stock price
  • Dividend
  • Payout ratio0.00%
  • Earnings date2026-11-05
  • P/E32.40
  • Future P/E6.93
  • EPS (ttm)0.24
  • EPS growth next 5 years

As of September 21, 2026

2026-11-206010.0032.280.050.45249.0032.94200.36-0.66+0.2200.40
2026-12-188810.0032.280.250.50269.0035.58147.58-3.31+0.27900.25
2027-03-1917912.5065.340.200.65514.0067.99138.64-2.65+0.2400.45
2027-03-1917910.0032.280.551.15299.0039.5580.65-7.28+0.40140.60

As of September 21, 2026

Sell covered calls with the data behind you

Find the best OPRX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial